BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du X, Shi L, Chen Z, Hu J, Zuo B, Xiong Y, Cao W. Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites. Front Cell Infect Microbiol 2022;12:836150. [DOI: 10.3389/fcimb.2022.836150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Chai Y, Xiao G, Liu Y, Xie X, Xiao W, Zhou P, Ma W, Zhang C, Li L. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1040350] [Reference Citation Analysis]
2 Liu X, Chen Q, Ji X, Yu W, Wang T, Han J, Li S, Liu J, Zeng F, Zhao Y, Zhang Y, Luo Q, Wang S, Wang F. Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor. Front Pharmacol 2022;13:939483. [DOI: 10.3389/fphar.2022.939483] [Reference Citation Analysis]